Hearing Loss: New Mechanism & Potential for Drug Repair
- For decades, scientists believed permanent hearing loss stemmed from a failure in the ion channels responsible for transmitting sound signals to the brain.
- A new study, to be presented at the February 21–25, 2026 70th Biophysical Society Annual Meeting in San Francisco, demonstrates that proteins essential for hearing – TMC1 and...
- Deep within the ear, specialized hair cells convert sound vibrations into electrical signals that the brain interprets as sound.
For decades, scientists believed permanent hearing loss stemmed from a failure in the ion channels responsible for transmitting sound signals to the brain. However, emerging research is revealing a more nuanced picture, identifying a previously overlooked culprit in the process of auditory decline.
A new study, to be presented at the 70th Biophysical Society Annual Meeting in San Francisco, demonstrates that proteins essential for hearing – TMC1 and TMC2 – also function as “lipid scramblases.” These scramblases maintain the integrity of cell membranes. When these proteins malfunction, triggered by factors like noise exposure, genetic predispositions, or even certain antibiotics, they disrupt the normal arrangement of fatty molecules within the membrane, initiating a self-destruct sequence in the delicate hair cells of the inner ear. Because these hair cells do not regenerate, this process leads to irreversible deafness.
Deep within the ear, specialized hair cells convert sound vibrations into electrical signals that the brain interprets as sound. These cells are named for the tiny, hair-like projections called stereocilia that bundle together. “When sound vibrations bend these hair-like structures, it opens channels that let ions flow into the cell, triggering a signal that carries sound to the brain,” explains Hubert Lee, a postdoctoral fellow at the National Institute on Deafness and Other Communication Disorders (NIDCD) at the National Institutes of Health.
“But when there’s a problem with these channel proteins, the hair cells die. And these cells don’t regenerate—so the hearing loss is permanent,” Lee adds.
TMC1 and TMC2 have long been studied for their role in converting sound into electrical signals, and mutations in these genes are a known cause of genetic deafness. However, the NIDCD team’s research reveals a previously unknown function of these proteins: regulating the cell membrane itself.
“We found that TMC1 and TMC2 are not only ion channels important for hearing—they also regulate the cell membrane,” says Angela Ballesteros, leading the research team. “And we think this membrane regulatory function, not the channel function, is what leads to hair cell death when things go wrong.”
Specifically, TMC1 and TMC2 act as lipid scramblases, molecular machines that move phospholipids – fatty molecules – from one side of the cell membrane to the other. Normally, different types of phospholipids are carefully organized on specific sides of the membrane. When phosphatidylserine, a particular phospholipid, is flipped to the outer surface of the cell, it acts as a signal that the cell is undergoing programmed cell death, or apoptosis.
“Hair cells from mouse models carrying mutations in TMC1 that cause hearing loss exhibit this membrane dysregulation—phosphatidylserine gets externalized, and the membrane starts blebbing and falling apart,” Ballesteros explains. “This is an apoptotic hallmark. It’s what’s killing the hair cells.”
This discovery also offers a potential explanation for why certain medications, such as aminoglycoside antibiotics, can cause hearing loss as a side effect. These antibiotics are known to damage hearing, and the researchers found that they activate the same membrane-disrupting scramblase activity within the hair cells.
“Scientists initially thought these drugs caused hearing loss by blocking the channel function of TMCs,” Lee notes. “But what we’re seeing now is that in the chaotic environment of the living hair cell, these drugs act as potent disruptors, triggering a collapse of membrane asymmetry.”
Further investigation revealed that the scramblase activity is influenced by cholesterol levels in the cell membrane. This finding suggests that dietary factors or cholesterol management strategies could potentially play a role in protecting hearing from damage caused by noise or ototoxic medications.
“If we understand the mechanism by which these drugs activate the scramblase, we might be able to design new drugs that lack this effect,” says Yein Christina Park, a graduate student at the NIH-JHU program and co-first author of the study. “We could potentially have antibiotics that don’t cause permanent hearing loss.”
Frequently Asked Questions
A: Humans are born with a finite number of sensory hair cells in the ear. Unlike skin or bone cells, these hair cells do not have the capacity to regenerate. Once the apoptotic signal is triggered, the cells are lost permanently.
A: Yes. Some antibiotics, known as aminoglycosides, are considered ototoxic. This research suggests they disrupt the function of proteins in the ear, leading to cell membrane instability and cell death.
A: Cholesterol contributes to the stability of cell membranes in the ear. The study indicates that the “death signal” is influenced by cholesterol levels, suggesting that maintaining membrane health could be a potential strategy for preventing hearing loss.
This research represents a significant step forward in understanding the complex mechanisms underlying permanent hearing loss. By identifying the role of TMC1 and TMC2 as lipid scramblases, scientists are opening new avenues for the development of therapies aimed at protecting and potentially restoring hearing.